[
    {
        "question": "Minimum interval between 2 live vaccine immunization -",
        "exp": "Ans. is 'b1 i.e., 4 weeks Basic principle of immunezationMinimum 4 week interval recommended between 2 live vaccine adminstration except OPVand oral thyphoid.Two or more killed vaccine may be administrated simultaneously or at any given internalA live and killed vaccine given simultaneously but at different site.If immunisation status unknown, give age appropriate vaccineMixing of vaccine in same syringe not recommendedLive vaccine should be avoided in AIDS,",
        "cop": 2,
        "opa": "2 weeks",
        "opb": "4 weeks",
        "opc": "6 week",
        "opd": "8 weeks",
        "subject_name": "Pediatrics",
        "topic_name": "Preventive Measures",
        "id": "e458f7de-4a60-4d5b-9393-4cec7750e852",
        "choice_type": "single"
    },
    {
        "question": "Influenza vaccine cause -",
        "exp": "Ans. is 'd' i.e., Ail of above o Mild problems following inactivated flu vaccine:Soreness, redness, or swelling where the shot was givenHoarsenessSore, red or itchy eyesCoughFeverAchesHeadacheItchingFatigueo If these problems occur, they usually begin soon after the shot and last 1 or 2 days.Moderate problems following inactivated flu vaccine:o Young children who get inactivated flu vaccine and pneumococcal vaccine (PCV13) at the same time may be at increased risk for seizures caused by fever. Ask your doctor for more information. Tell your doctor if a child who is getting flu vaccine has ever had a seizure.Problems that could happen after any vaccine:o Brief fainting spells can happen after any medical procedure, including vaccination. Sitting or lying down for about 15 minutes can help prevent fainting, and injuries caused by a fall. Tell your doctor if you feel dizzy* or have vision changes or ringing in the ears.o Severe shoulder pain and reduced range of motion in the arm where a shot was given can happen, very rarely, after a vaccination.o Severe allergic reactions from a vaccine are very rare, estimated at less than 1 in a million doses. If one were to occur, it wrould usually be within a few minutes to a fewr hours after the vaccination.",
        "cop": 4,
        "opa": "Local swelling",
        "opb": "Fever",
        "opc": "Itching",
        "opd": "All of above",
        "subject_name": "Pediatrics",
        "topic_name": "Preventive Measures",
        "id": "bd380ae7-5642-41ce-8af0-d6c0ed4e75cf",
        "choice_type": "multi"
    },
    {
        "question": "After splenectomy which vaccine has to be given-",
        "exp": "Ans. is 'a' i.e., Pneumococal o Children at hight risk of pneumococal disease :-Congenital immunodeficiencyHIVImmunosuppresant drugSickle cell diseaseAsplenia, post splenectomyChronic cardiac diseaseChronic pulmonary, renal diseaseDiabetes mellitus",
        "cop": 1,
        "opa": "Pneumococal",
        "opb": "Rotavirus",
        "opc": "BCG",
        "opd": "MMR",
        "subject_name": "Pediatrics",
        "topic_name": "Preventive Measures",
        "id": "5e044b13-8110-4f6d-b26c-e0f92abe415c",
        "choice_type": "single"
    },
    {
        "question": "Baby with history of convulsion vaccine contraindicated is -",
        "exp": "Ans. is 'a' i.e., DPT Guide to Contraindications1 and Precautions to Commonly Used VaccinesVaccineContraindicationsPrecautionsHepatitis B (HepB)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero Infant weighing less than 2000 grams (4 lbs, 6.4 oz)Rotavirus (RV5 , RV1 (Rotarix])o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Severe combined immunodeficiency (SCID)o History of intussusceptiono Moderate or severe acute illness with or without fevero Altered immunocompetence other than SCIDo Chronic gastrointestinal diseaseo Spina bifida or bladder exstrophyDiphtheria,tetanus, pertussis(DTaP)Tetanus,diphtheria,pertussis (Tdap)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento For pertussis-containing vaccines: encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) not attributable to another identifiable cause within 7 days of administration of a previous dose of DTP or DTaP ( for DTaP); or of previous dose of DTP, DTaP, or Tdap (for Tdap)o Moderate or severe acute illness with or without fevero Guillain-Barre syndrome (GBS) within 6 weeks after a previous dose of tetanus toxoid-containing vaccineo History of arthus-type hypersensitivity reactions after a previous dose of tetanus or diphtheria toxoid-containing vaccine; defer vaccination until at least 10 years have elapsed since the last tetanus-toxoid containing vaccineo For pertussis-containing vaccines: progressive or unstable neurologic disorder (including infantile spasms for DTaP), uncontrolled seizures, or progressive encephalopathy until a treatment regimen has been established and the condition has stabilizedTetanus,diphtheria (DT, Td)For DTaP only:o Temperature of 105deg F or higher (4Q.5CC or higher) whthin 48 hours after vaccination with a previous dose of DTP.'DTaPo Collapse or shock-like state (i.e., hypotonic hyporesponsive episode) within 48 hours after receiving a previous dose of DTP/DTaPo Seizure within 3 days after receiving a previous dose of DTP DTaPo Persistent, inconsolable crying lasting 3 or more hours within 48 hours after receiving a previous dose of DTP.' DTaPHaemophilus influenzae type b (Hib)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Age younger than 6 weekso Moderate or severe acute illness with or without feverInactivatedPoliovirusvaccine (IPV)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero PregnancyPneumococcal(PCV13 orPPSV23)o For PCV13, severe allergic reaction (e.g., anaphylaxis) after a previous dose of PCV7 or PCV13 or to a vaccine component, including to any vaccine containing diphtheria toxoido For PPSV23, severe allergic reaction (e.g.. anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverMeasles, mumps,rubella (MMR)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Known severe immunodeficiency (e.g., from hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, or long-term immunosuppressive therapy5 or patients with human immunodeficiency virus infection who are severely immunocompromised)o Pregnancyo Moderate or severe acute illness with or without fevero Recent (within 11 months) receipt of antibody-containing blood product (specific interval depends on product)o History of thrombocytopenia or thrombocytopenic purpurao Need for tuberculin skin testingVaricella (Var)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Known severe immunodeficiency (e.g., from hematologic and solid tumors, receipt of chemotherapy, primary or acquired immunodeficiency, or long-term immunosuppressive therapy''1 or patients with HIV infection wrho are severely immunocompromised)- o Pregnancyo Moderate or severe acute illness with or without fevero Recent (within 11 months) receipt of antibody-containing blood product (specific interval depends on product)o Receipt of specific antivirals (i.e., acyclovir, famciclovir, or valacvclo- vir) 24 hours before vaccination; avoid use of these antiviral drugs for 14 days after vaccinationHepatitis A(HepA)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverInfluenza,Inactivatedinjectable (IIV)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any IIV or LAIV or to a vaccine component, including egg proteino Moderate or severe acute illness with or without fevero History of GBS within 6 weeks of previous influenza vaccinationo Persons who experience only hives with exposure to eggs may receive RIV (if age 18-49) or, with additional safety' precautions, IIV.Influenza,recombinant (RIV)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose of RIV or to a vaccine component. RIV does not contain any egg protein.o Moderate or severe acute illness with or without fevero History of GBS within 6 weeks of previous influenza vaccinationInfluenza, liveattenuated(LAIV)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose of IIV or LAIV or to a vaccine component, including egg proteino Conditions for which the AC IP recommends against use, but which are not contraindications in vaccine package insert: immune suppression, certain chronic medical conditions such as asthma, diabetes, heart or kidney disease, and pregnancyo Moderate or severe acute illness with or without fevero History of GBS within 6 weeks of previous influenza vaccinationo Receipt of specific antivirals (i.e., amantadine, rimantadine, zanamivir, or oseltamivir) 48 hours before vaccination. Avoid use of these antiviral drugs for 14 days after vaccination.Humanpapillomavirus(HPV)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without fevero PregnancyMeningococcal:conjugate (MCV4),polysaccharide (MPSV4)o Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a vaccine componento Moderate or severe acute illness with or without feverZoster (HZV)o Severe allergic reaction (e.g., anaphylaxis) to a vaccine componento Known severe immunodeficiency (e.g.. from hematologic and solid tumors, receipt of chemotherapy, or long-term immunosuppressive therapy5 or patients with HIV infection who are severely immunocompromised),o Pregnancyo Moderate or severe acute illness with or without fevero Receipt of specific antivirals (i.e., acyclovir, famciclovir, or valacyclovir) 24 hours before vaccination; avoid use of these antiviral drugs for 14 days after vaccination",
        "cop": 1,
        "opa": "DPT",
        "opb": "Measles",
        "opc": "BCG",
        "opd": "Rubella",
        "subject_name": "Pediatrics",
        "topic_name": "Preventive Measures",
        "id": "e4474ad9-cbf9-44bd-bb31-824fee2297fe",
        "choice_type": "single"
    }
]